InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

Current share price for NOX : $0.080 0.001 (1.23%)+

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Noxopharm Alliance With GenesisCare 18 Feb 2020 8:59AM $0.270 $0.080 fallen by 70.37%
$25 Proposed issue of Securities - NOX 14 Feb 2020 10:10AM $0.225 $0.080 fallen by 64.44%
$25 $8.1M Financing & Re-Set of Capital Structure 14 Feb 2020 10:09AM $0.225 $0.080 fallen by 64.44%
$25 Pronounced survival benefit in LuPIN interim trial data 14 Feb 2020 8:55AM $0.225 $0.080 fallen by 64.44%
$25 Trading Halt 12 Feb 2020 9:11AM $0.225 $0.080 fallen by 64.44%
$25 LuPIN interim trial data to be presented at ASCO GU 2020 11 Feb 2020 8:32AM $0.215 $0.080 fallen by 62.79%
$25 Lapsing of Unlisted Options 6 Feb 2020 4:40PM $0.220 $0.080 fallen by 63.64%
$25 Noxopharm Dec 2019 Appendix 4C 31 Jan 2020 9:15AM $0.240 $0.080 fallen by 66.67%
$25 Noxopharm Non-Deal Roadshow Presentation 29 Jan 2020 9:20AM $0.250 $0.080 fallen by 68%
$25 Appendix 3B 20 Jan 2020 9:01AM $0.275 $0.080 fallen by 70.91%
$25 Listing of Nyrada Inc. spin-off on ASX 16 Jan 2020 11:32AM $0.260 $0.080 fallen by 69.23%
$25 Becoming a substantial holder for NYR 16 Jan 2020 10:00AM $0.290 $0.080 fallen by 72.41%
$25 Noxopharm Corporate Presentation 15 Jan 2020 1:06PM $0.260 $0.080 fallen by 69.23%
$25 Ceasing to be a substantial holder 27 Dec 2019 1:33PM $0.285 $0.080 fallen by 71.93%
$25 Change of Director's Interest Notice - GK 23 Dec 2019 8:44AM $0.292 $0.080 fallen by 72.60%
$25 Section 708 Certificate 23 Dec 2019 8:39AM $0.292 $0.080 fallen by 72.60%
$25 Appendix 3B 23 Dec 2019 8:23AM $0.292 $0.080 fallen by 72.60%
$25 DARRT-1 Clinical Data Webinar 20 Dec 2019 9:04AM $0.310 $0.080 fallen by 74.19%
$25 Nyrada IPO Offer Fully Subscribed 17 Dec 2019 9:55AM $0.255 $0.080 fallen by 68.63%
$25 Unlisted Options Expiring 18 January 2020 13 Dec 2019 2:05PM $0.258 $0.080 fallen by 68.93%
$25 Lodgement of Nyrada Inc Supplementary Prospectus 9 Dec 2019 10:18AM $0.330 $0.080 fallen by 75.76%
$25 Nyrada Inc Initial Public Offering Opens 4 Dec 2019 9:01AM $0.350 $0.080 fallen by 77.14%
$25 Section 708 Certificate - Notes 3 Dec 2019 1:09PM $0.360 $0.080 fallen by 77.78%
$25 Section 708 Certificate 3 Dec 2019 1:03PM $0.360 $0.080 fallen by 77.78%
$25 Appendix 3B 3 Dec 2019 1:03PM $0.360 $0.080 fallen by 77.78%

451 - 475 of 797 results

Page 19 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.